Literature DB >> 8586083

Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid.

J Taki1, K Nakajima, I Matsunari, H Bunko, S Takada, N Tonami.   

Abstract

In coronary artery disease, discrepancy in the uptake of thallium-201 and of methyl-branched fatty acid at rest has been described. The purpose of this study was to evaluate iodine-123 labelled beta-methyl-branched fatty acid (BMIPP) myocardial uptake and wall motion at rest in segments with stress-induced ischaemia identified by stress 201Tl tomography in patients with chronic coronary artery disease. 123I-BMIPP myocardial tomography was performed at rest and was compared with the findings of exercise-reinjection 201Tl tomography in 45 patients with chronic coronary artery disease. Regional wall motion was evaluated by contrast left ventriculography in 36 patients. Among 237 segments with reversible 201Tl defects, equally decreased uptake on both reinjection 201Tl and BMIPP images was observed in 93 (39%), more severely decreased uptake of BMIPP in 118 (50%) and more severely decreased uptake of reinjection 201Tl in 26 (11%). On the other hand, among 90 segments with non-reversible 201Tl defects, each pattern was observed in 71 (79%), 6 (7%) and 13 (14%) segments, respectively. When comparing the ischaemic segments with and without more severely reduced uptake of BMIPP than of reinjection 201Tl, wall motion was impaired to a greater extent in the segments with more severely reduced uptake of BMIPP than of reinjection 201Tl [severe hypo- or dyskinesis was present in 64 (70%) of 91 segments and in 24 (22%) of 110 segments, respectively, P<0.005]. In patients with chronic coronary artery disease, resting fatty acid uptake was frequently more reduced than reinjection 201Tl in the segments with stress-induced ischaemia, while in most of the fixed perfusion defects BMIPP and reinjection 201Tl uptake decreased concordantly. In ischaemic myocardium, wall motion was impaired to a greater extent in those segments which showed more severely reduced uptake of BMIPP than of reinjection 201Tl. In ischaemic but viable myocardium, discordant BMIPP uptake less than reinjection 201Tl uptake may indicate metabolic alterations and wall motion abnormality at rest independent of perfusion abnormalities. In conclusion, the combination of resting BMIPP and stress-reinjection 201Tl imaging may provide information on metabolic alterations and wall motion abnormality at rest independent of perfusion abnormalities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586083     DOI: 10.1007/bf01791146

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  31 in total

1.  Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration.

Authors:  Y Fujibayashi; Y Yonekura; Y Takemura; K Wada; K Matsumoto; N Tamaki; K Yamamoto; J Konishi; A Yokoyama
Journal:  J Nucl Med       Date:  1990-11       Impact factor: 10.057

2.  The hibernating myocardium.

Authors:  S H Rahimtoola
Journal:  Am Heart J       Date:  1989-01       Impact factor: 4.749

3.  Twenty-four-hour quantitative thallium imaging for predicting beneficial revascularization.

Authors:  J Taki; K Nakajima; H Bunko; M Kawasuji; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1994-11

4.  C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium.

Authors:  H R Schön; H R Schelbert; G Robinson; A Najafi; S C Huang; H Hansen; J Barrio; D E Kuhl; M E Phelps
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

5.  Measurement of myocardial fatty acid metabolism: kinetics of iodine-123 heptadecanoic acid in normal dog hearts.

Authors:  H R Schön; R Senekowitsch; D Berg; M Schneidereit; G Reidel; H Kriegel; H W Pabst; H Blömer
Journal:  J Nucl Med       Date:  1986-09       Impact factor: 10.057

6.  Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy.

Authors:  C Kurata; K Tawarahara; T Taguchi; S Aoshima; A Kobayashi; N Yamazaki; H Kawai; M Kaneko
Journal:  J Nucl Med       Date:  1992-01       Impact factor: 10.057

7.  Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.

Authors:  Y Takeishi; J Chiba; S Abe; I Tonooka; A Komatani; H Tomoike
Journal:  Eur J Nucl Med       Date:  1992

8.  Iodine-123 phenylpentadecanoic acid: detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography.

Authors:  J S Rellas; J R Corbett; P Kulkarni; C Morgan; M D Devous; L M Buja; L Bush; R W Parkey; J T Willerson; S E Lewis
Journal:  Am J Cardiol       Date:  1983-12-01       Impact factor: 2.778

9.  Fatty acid myocardial imaging using 123I-beta-methyl-iodophenyl pentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model).

Authors:  T Nishimura; M Sago; K Kihara; H Oka; T Shimonagata; T Katabuchi; M Hayashi; T Uehara; K Hayashida; H Noda
Journal:  Eur J Nucl Med       Date:  1989

10.  Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of 99mTc-Sestamibi and 123I-beta-methyl-iodo-phenyl pentadecanoic acid.

Authors:  F De Geeter; P R Franken; F F Knapp; A Bossuyt
Journal:  Eur J Nucl Med       Date:  1994-04
View more
  8 in total

Review 1.  Future aspects of BMIPP.

Authors:  N Tamaki; K Morita; E Tsukamoto; Y Kawai
Journal:  Int J Card Imaging       Date:  1999-02

Review 2.  The Japanese experience with metabolic imaging in the clinical setting.

Authors:  Nagara Tamaki; Koichi Morita; Yuko Kawai
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 3.  BMIPP compared with thallium redistribution.

Authors:  J Taki; I Matsunari; K Nakajima; N Tonami
Journal:  Int J Card Imaging       Date:  1999-02

Review 4.  Radionuclide techniques for the assessment of myocardial viability.

Authors:  E Skoufis; A I McGhie
Journal:  Tex Heart Inst J       Date:  1998

5.  Nonperfusion applications in nuclear cardiology: report of a task force of the American Society of Nuclear Cardiology.

Authors:  E G DePuey; S Port; F J Wackers; A Rozanski; E H Botvinick; M W Dae; N Tamaki
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

Review 6.  Advantages and limitations of experimental techniques used to measure cardiac energy metabolism.

Authors:  G D Lopaschuk
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

7.  Absent myocardial I-123 BMIPP uptake in a family.

Authors:  E H Hwang; A Yamashita; H Takemori; J Taki; K Nakajima; H Bunko; S Nakamura; T Ikeda; N Tonami
Journal:  Ann Nucl Med       Date:  1996-11       Impact factor: 2.668

Review 8.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.